Betta Pharmaceuticals Co., Ltd. (300558) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Betta Pharmaceuticals Co., Ltd.

Why is Betta Pharmaceuticals Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 15.17% and Operating profit at 9.21% over the last 5 years

With ROE of 5.72%, it has a very expensive valuation with a 2.98 Price to Book Value

Over the past year, while the stock has generated a return of 6.17%, its profits have fallen by -18.2%
At the current price, the company has a high dividend yield of 0.7

Underperformed the market in the last 1 year

The stock has generated a return of 6.17% in the last 1 year, much lower than market (China Shanghai Composite) returns of 21.43%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Betta Pharmaceuticals Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Betta Pharmaceuticals Co., Ltd.

6.17%

1.28

45.27%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.17%

EBIT Growth (5y)

9.21%

EBIT to Interest (avg)

9.58

Debt to EBITDA (avg)

1.94

Net Debt to Equity (avg)

0.31

Sales to Capital Employed (avg)

0.37

Tax Ratio

5.06%

Dividend Payout Ratio

20.63%

Pledged Shares

Institutional Holding

ROCE (avg)

5.85%

ROE (avg)

7.69%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.98

EV to EBIT

35.87

EV to EBITDA

21.48

EV to Capital Employed

2.53

EV to Sales

5.96

PEG Ratio

Dividend Yield

0.71%

ROCE (Latest)

7.05%

ROE (Latest)

5.72%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 3.04 times

RAW MATERIAL COST(Y)

Fallen by -10.19% (YoY

NET SALES(Q)

Highest at CNY 1,039.84 MM

PRE-TAX PROFIT(Q)

Highest at CNY 268.22 MM

NET PROFIT(Q)

Highest at CNY 215.91 MM

EPS(Q)

Highest at CNY 0.56

-9What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 878.33 MM

INTEREST(9M)

At CNY 55.22 MM has Grown at 23.09%

CASH AND EQV(HY)

Lowest at CNY 1,006.21 MM

Here's what is working for Betta Pharmaceuticals Co., Ltd.

Pre-Tax Profit

At CNY 268.22 MM has Grown at 117.32%

over average net sales of the previous four periods of CNY 123.42 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 215.91 MM has Grown at 154.65%

over average net sales of the previous four periods of CNY 84.78 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 3.04 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales

Highest at CNY 1,039.84 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 268.22 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 215.91 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.56

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -10.19% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Betta Pharmaceuticals Co., Ltd.

Interest

At CNY 55.22 MM has Grown at 23.09%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 878.33 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Cash and Eqv

Lowest at CNY 1,006.21 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents